{"id":"https://openalex.org/W3030754855","doi":"https://doi.org/10.1145/3380625.3380629","title":"Research on Enterprise Internal Control Risk Based on Kangmei Pharmaceutical Event","display_name":"Research on Enterprise Internal Control Risk Based on Kangmei Pharmaceutical Event","publication_year":2020,"publication_date":"2020-01-17","ids":{"openalex":"https://openalex.org/W3030754855","doi":"https://doi.org/10.1145/3380625.3380629","mag":"3030754855"},"language":"en","primary_location":{"is_oa":false,"landing_page_url":"https://doi.org/10.1145/3380625.3380629","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false},"type":"article","type_crossref":"proceedings-article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101080321","display_name":"Tianqi Song","orcid":null},"institutions":[{"id":"https://openalex.org/I196699116","display_name":"Wuhan University of Technology","ror":"https://ror.org/03fe7t173","country_code":"CN","type":"education","lineage":["https://openalex.org/I196699116"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tianqi Song","raw_affiliation_strings":["School of Management, Wuhan University of Technology, Wuhan, P.R.China, CHN"],"affiliations":[{"raw_affiliation_string":"School of Management, Wuhan University of Technology, Wuhan, P.R.China, CHN","institution_ids":["https://openalex.org/I196699116"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100650024","display_name":"Xiaoyi Chen","orcid":"https://orcid.org/0000-0002-7125-3932"},"institutions":[{"id":"https://openalex.org/I196699116","display_name":"Wuhan University of Technology","ror":"https://ror.org/03fe7t173","country_code":"CN","type":"education","lineage":["https://openalex.org/I196699116"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoyi Chen","raw_affiliation_strings":["School of Management, Wuhan University of Technology, Wuhan, P.R.China, CHN"],"affiliations":[{"raw_affiliation_string":"School of Management, Wuhan University of Technology, Wuhan, P.R.China, CHN","institution_ids":["https://openalex.org/I196699116"]}]}],"institution_assertions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":0,"max":60},"biblio":{"volume":null,"issue":null,"first_page":"184","last_page":"189"},"is_retracted":false,"is_paratext":false,"primary_topic":{"id":"https://openalex.org/T12276","display_name":"Risk Management in Financial Firms","score":0.7959,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12276","display_name":"Risk Management in Financial Firms","score":0.7959,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10081","display_name":"Auditing, Earnings Management, Governance","score":0.7776,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/internal-control","display_name":"Internal control","score":0.6624031}],"concepts":[{"id":"https://openalex.org/C199450454","wikidata":"https://www.wikidata.org/wiki/Q1667931","display_name":"Internal control","level":3,"score":0.6624031},{"id":"https://openalex.org/C2775924081","wikidata":"https://www.wikidata.org/wiki/Q55608371","display_name":"Control (management)","level":2,"score":0.6399699},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6183189},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.4528398},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.37728834},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.33496538},{"id":"https://openalex.org/C21547014","wikidata":"https://www.wikidata.org/wiki/Q1423657","display_name":"Operations management","level":1,"score":0.3240298},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.23930717},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.12285313},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C199521495","wikidata":"https://www.wikidata.org/wiki/Q181487","display_name":"Audit","level":2,"score":0.0},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"is_oa":false,"landing_page_url":"https://doi.org/10.1145/3380625.3380629","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.52,"id":"https://metadata.un.org/sdg/9","display_name":"Industry, innovation and infrastructure"}],"grants":[],"datasets":[],"versions":[],"referenced_works_count":1,"referenced_works":["https://openalex.org/W2901646679"],"related_works":["https://openalex.org/W57911776","https://openalex.org/W4290804300","https://openalex.org/W3196420090","https://openalex.org/W3121785297","https://openalex.org/W2618663374","https://openalex.org/W2595448336","https://openalex.org/W2016662386","https://openalex.org/W1996137866","https://openalex.org/W1044452674","https://openalex.org/W101937606"],"abstract_inverted_index":{"In":[0],"the":[1,14,17,33,44,54,57,67,72,80,91,95,106,121,124,133,150,161],"current":[2],"increasingly":[3],"competitive":[4],"market":[5],"environment,":[6],"effective":[7],"and":[8,19,24,47,71,104,155],"efficient":[9],"internal":[10,36,76,96,128,134,145,164],"control":[11,37,77,97,129,135,146,165],"has":[12],"become":[13],"key":[15],"to":[16,131,148,157],"rise":[18],"fall":[20],"of":[21,30,35,50,56,61,75,86,99,123,127,137,142,152,163,166],"enterprise's":[22,153],"production":[23],"operation.":[25],"As":[26],"an":[27,39],"important":[28,40],"means":[29],"enterprise":[31,144],"management,":[32],"construction":[34],"plays":[38],"fundamental":[41],"role":[42],"in":[43,79,94,120,169],"stability,":[45],"health":[46],"sustainable":[48],"development":[49],"enterprises.":[51,138],"Based":[52],"on":[53],"investigation":[55],"\"three-year":[58],"earnings":[59],"report":[60],"Kangmei":[62,100,110],"Pharmaceutical":[63,101,111],"Co.,":[64,102,112],"Ltd.":[65,103,113],"by":[66],"Securities":[68],"Regulatory":[69],"Commission\"":[70],"five":[73,125],"elements":[74,126],"involved":[78],"\"Basic":[81],"Standards":[82],"for":[83,160],"Internal":[84],"Control":[85],"Enterprises\",":[87],"this":[88],"paper":[89],"analyses":[90],"problems":[92],"existing":[93],"system":[98,136],"explores":[105],"underlying":[107],"causes,":[108],"nconcludes":[109],"The":[114],"conclusion":[115],"that":[116],"there":[117],"are":[118],"defects":[119],"implementation":[122],"is":[130],"rebuild":[132],"Through":[139],"continuous":[140],"improvement":[141,162],"innovative":[143],"system,":[147],"improve":[149],"level":[151],"management":[154],"quality,":[156],"provide":[158],"reference":[159],"pharmaceutical":[167],"enterprises":[168],"China.":[170]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3030754855","counts_by_year":[],"updated_date":"2024-12-27T01:59:22.891469","created_date":"2020-06-05"}